Publicité
Publicité

Contenu connexe

Publicité
Publicité

Small pox and chickenpox

  1. EPIDEMIOLOGY OF SMALL POX Mrs. NAMITA BATRA GUIN ASSOCIATE PROFESSOR COMMUNITY HEALTH NURSING
  2. INTRODUCTION • Smallpox is a serious, contagious and sometimes fatal disease • At its height, 10-15 million cases a year, with 2 million deaths • There is no specific treatment for smallpox, and the only prevention is vaccination. • The name smallpox is derived from the Latin word “spotted” and refers to the raised bumps that appear on the face and body of an infected person. • It is caused by variola virus, Orthopoxvirus genus
  3. HISTORY • Mummified remains of Ramses. (1157 B.C.)
  4. HISTORY • Smallpox was likely carried from Egyptian traders to India • By 1967 it became a major killer in not less than 33 countries • Those who survive became immune • As a result, physicians intentionally infected healthy persons with smallpox organisms
  5. VARIOLATION • It is the act of taking samples (pus from pustules or ground scabs) from patients whose disease had been benign, and introducing it into others through the nose or skin
  6. EDWARD JENNER
  7. EDWARD JENNER’S CONTRIBUTION • He found that, the cowpox would protect the patient from smallpox • He proposed it in 1798 • In England vaccination with cowpox became compulsory in 1853 • Jenner was honoured for his technique, and ‘Vaccine’ became the universally used term to indicate introducing material under the skin to produce a protection against disease
  8. EPIDEMIOLOGY • Smallpox is no more, due to aggressive vaccination campaign by WHO. • It is believed that the virus began in rodents, and as prehistoric man killed and ate the rodents, the virus was passed on to humans. Once humans became the new host, there was no stopping the deadly viruses spread of devastation. • This was due to the fact that around 9000 BC humans began to cultivate crops and settle into much larger communities. With larger groups, the virus could move from person to person without exhausting its supply of hosts.
  9. VARIOLA VIRUS
  10. CAUSATIVE AGENT • Smallpox is caused by 2 variations of the virus variola. • The deadliest form is Variola Major. • This is the largest animal virus visible with light microscope appear as smooth rounded rectangles. • It is the only virus that do not need a cell’s nucleus to replicate and are larger than some bacteria. • Variola Minor can leave large scars and can possibly cause blindness. • Smallpox is a highly contagious disease with a long incubation period, usually between 12-14 days.
  11. PATHOGENESIS • Portal of entry: respiratory tract or inoculation on skin • Source of infection: Excretions from the mouth and nose, rather than scabs • During incubation the virus proceeds through infection, replication, and liberation (usually accompanied by cell necrosis) first at the site of inoculation and then to the regional lymph nodes, then deeper lymph nodes and bloodstream
  12. PATHOGENESIS • 4 orthopoxviruses are known to infect humans: variola, vaccinia, cowpox, and monkeypox • Variola major is severe and the most common form with more extensive rash and higher fever with a death rate of 30% • Variola minor has less common presentation and much less severe with death rate of 1%
  13. PATHOGENESIS • Variola Major has 3 clinical presentations based on the nature and evolution of the lesions: – Ordinary: most frequent, corresponds to classical description – Modified: milder and may occur in previously vaccinated people; rarely fatal – Flat and Hemorrhagic: very severe but uncommon
  14. PATHOGENESIS • The multiplication cycle starts by the virus binding to a host cycle. • Once in the host cell, it will un coat the exterior enveloped virion, and then un coats the inner enveloped virion. • Now that the inner enveloped virion is uncoated, the DNA uncoils along with multiple viral enzymes. • This process starts the replication of the genome that occurs in the cytoplasm. • This also makes smallpox unique in that replication usually takes place in the nucleus, not the cytoplasm, since viruses generally don’t have cytoplasm. • Once the DNA replicates to make a virion, the virion then passes through the cell membrane and is enveloped simultaneously and is then released to repeat the process.
  15. TRANSMISSION • Humans are the only natural host of smallpox (no animal reservoir) • Transmission generally occurs from direct and fairly prolonged face-to-face contact, usually within a distance of 6 feet (1.8 m). • Infected aerosols and air droplets spread in face-to-face contact • The virus can cross the placenta, but the incidence of congenital smallpox is relatively low.
  16. STAGES OF SMALL POX • Incubation Period – 12-14 days, person is not contagious • Prodrome Phase – Begins abruptly with fever, malaise, headache, head and body aches, prostration, and often nausea and vomiting – Body temperature rises to at least 101 F and is often higher • When the first visible lesions appear the fever may start to go down - most contagious period • Rash emerges as small red spots on tongue and in mouth (about 24 hours before the appearance of rash on the skin) • Lesions in the mouth and pharynx enlarge and ulcerate quickly, releasing large amount of virus into the saliva
  17. STAGES OF SMALL POX • Rash Phase • Centrifugal distribution • Palms and soles are involved • lesions are all in the same stage of development on that part of the body (unlike chickenpox)
  18. PATHOLOGIC FEATURES Skin: Capillaries in the papillary dermis dilate, cells enlarge, vacuolate, and degenerate. Affected cells contain round or oval inclusion bodies, called Guarnieri's bodies, that measure 2 to 8 µm, and compose of viral particles and proteins; each body is the locus of viral replication and assembly. Later, viral inclusions occupy large portions of cytoplasm. Cells may lose normal orientation, condense, and detach. Cellular degeneration spreads in the middle layer of the epidermis. Respiratory and Digestive Tracts: Smallpox can affect the epithelium of the tongue, throat, trachea, gullet, and appendix Necrosis begins in superficial cells, and then penetrates to form ulcers. The trachea may have sharply defects 1 to 2 mm in diameter.
  19. PATHOLOGIC FEATURES Lungs: Alveolar cells are swollen, mitotic, or degenerating with accompanying bacterial growth. Heart: Cardiac involvement in smallpox is not often but can include hyperemia and small hemorrhages. Liver: Endothelial cells become swollen and necrotic. Spleen: The spleen is enlarged and engorged with blood, and there are small hemorrhages in the red and white pulp. Kidney: Pathologic changes in the kidney are most prominent in the center (medulla). Tubular epithelial cells are swollen, degenerated, or mitotic.
  20. OUTCOME OF INFECTION • Those who survive usually have scars • In eye involvement, blindness could occur • Recovery results in long lasting immunity • No evidence of chronic or recurrent infection
  21. VACCINATION • Live vaccine virus • Administered using a bifurcated needle, not an injection • Bifurcated needle is dipped into the vaccine and then used to prick the skin 15 times in about 3 seconds in a 5mm radius area • Administered into the superficial layer of the skin
  22. COURSE OF VACCINATION • If vaccination is successful a red, itchy bump develops at the vaccine site in 3-4 days; a papule surrounded by erythema • In the first week the bump becomes a blister, fills with pus, and begins to drain • During the second week the blister begins to dry and a scab forms; the scab then falls off leaving a scar • It is given on the right side universally
  23. CONTROL • Only after WWI most of Europe become smallpox free, and only after WWII transmission stopped throughout Europe and North America • In developing countries smallpox continued largely unabated until middle of 20th century • 1958: Soviet Union proposed to the WHO that a global smallpox eradication program be undertaken
  24. CONTROL • The campaign was based on a two fold strategy – 1. Mass vaccination campaigns in each country using a vaccine of ensured potency and stability that would reach at least 80% of the population – 2. Surveillance-Containment - isolation of patients and the vaccination of family members and other contacts in the immediate vicinity
  25. CONTROL • Ring vaccination: The strategy involves the following steps: – Rapid identification and isolation of all smallpox cases – Identification and vaccination of contacts of smallpox cases – Monitoring contacts for development of fever and isolating them if fever occurs – Vaccination of household members of contacts if no contraindications to vaccination exist
  26. MANAGEMENT OF AN OUTBREAK • Surveillance is easier because of the distinctive rash • Containment involves efficient detection of cases and identification and vaccination of contacts • Patients diagnosed with smallpox should be physically isolated • All specimen collectors, care givers and attendants coming into close contact with patients should be vaccinated • Medical care givers, attendants, and mortuary workers should wear gloves, caps, gowns, and surgical masks
  27. MANAGEMENT OF AN OUTBREAK • Contaminated clothing and bedding, if not incinerated, should be autoclaved or washed in hot water containing bleach • Fumigation of premises with formaldehyde • Airborne and Contact Precautions in addition to Standard Precautions should be implemented for patients with suspected smallpox
  28. ERADICATION • In India : Last case reported on 17th May 1975 in Bihar • In April 1977 declared free from smallpox • 26th October 1977 the last naturally occurring case of smallpox was recorded in Somalia • In 1978 two cases were reported. These were both from people working in labs with smallpox in England • 8th May 1980, WHO declared that smallpox has been eradicated
  29. FACTORS THAT LED TO ERADICATION • Epidemiological factors: – No known animal reservoir – No long-term carrier of the virus – Life-long immunity after recovery from the disease – Detection of cases, the rash was so characteristic – Sub-clinical infection did not transmit the disease – Vaccine highly effective – International co-operation
  30. EPIDEMIOLOGY OF CHICKEN POX
  31. INTRODUCTION • Acute, highly infectious disease caused by Varicella- Zoster (V–Z) virus • Chicken pecked skin appearance, chickpea appearance • World-wide in distribution and occurs in endemic and epidemic forms • Chickenpox and Herpes zoster as different host responses to the same etiological agent • In India, approx. 28,000 cases per year
  32. EPIDEMIOLOGICAL DETERMINANTS: AGENT • Agent: Human (alpha) herpes virus – Primary infection causes chicken pox – Recovery followed by latent infection – Reactivation results in zoster- a painful, vesicular, pustular eruption in distribution of one or more sensory nerve roots – Can be grown in tissue culture • Incubation period: 14-16 days (7-21 days)
  33. EPIDEMIOLOGICAL DETERMINANTS:AGENT • Source of infection • Usually a case of chicken pox • Virus present in oropharyngeal secretions and lesions of skin and mucosa • Rarely may be a patient with herpes zoster • It can be isolated from the vesicular fluid during the first 3 days of illness
  34. EPIDEMIOLOGICAL DETERMINANTS: HOST •Age – Children under 10 years of age – Few escape until adulthood but can be severe in adults • Immunity – One attack give durable immunity – Maternal antibody protects the infant for few months – No age is exempt in the absence of immunity – IgG antibodies persist for life and correlate with protection – Cell mediated immunity is important in recovery • Pregnancy: Risk for fetus and neonate
  35. EPIDEMIOLOGICAL DETERMINANTS: ENVIRONMENTAL •It shows a seasonal trend, occurring mostly during the first six months of the year • Overcrowding • In temperate climates, there is little evidence of seasonal trend
  36. TRANSMISSION •Droplet infection and droplet nuclei • ‘Face to face’ (personal) contact • Portal of entry: respiratory tract • Virus is extremely labile, so fomites unlikely to transmit • Contact infection plays a significant role when an individual with herpes is an index case • Congenital varicella - it crosses the placental barrier and infects the foetus
  37. CLINICAL FEATURES •Clinical spectrum – Mild illness with few scattered lesions – Severe febrile illness with widespread rash • Pre-eruptive stage – Sudden onset with mild to moderate fever – Pain in the back, shivering and malaise – Duration about 24 hours – In adults, prodromal illness is usually more severe and may last for 2-3 days before the rash
  38. CLINICAL FEATURES • Eruptive stage: in children the rash comes on day the fever starts and first sign • The distinctive features of rash are – Rash is symmetrical – Appears on the trunk and then comes to face, arms ,legs – Mucosal surfaces (buccal, pharyngeal) are involved – Axilla affected. Palms and soles usually not involved – The density of eruption diminishes centrifugally – Pleomorphism - All stages of rash (papules, vesicles and crusts) may be seen simultaneously in the same area
  39. CLINICAL FEATURES • Evolution of rashes – The rash advances quickly through the stages of- macule, papule, vesicle, scab – Vesicles filled with clear fluid resembling ‘dew-drops’ – Superficial in site, with easily ruptured walls and surrounded by an area of inflammation – Vesicles may form crusts directly. Many lesions may abort – Scabbing begins 4-7 days after the rash appears • Fever not high but exacerbations with fresh crop
  40. COMPLICATIONS • It’s a mild, self-limiting disease • Patients at risk of complications are – Immunosuppressive patients – Cancer patients – Recipients of organ transplants – Chemo, radio, steroid therapy recipients – HIV infected – Children with leukemia
  41. COMPLICATIONS • Haemorrhages (varicella haemorrhagic) • Pneumonia • Encephalitis • Acute cerebellar ataxia • Reye’s syndrome • Maternal varicella may cause foetal wastage & birth defects • Acute retinal necrosis • Secondary bacterial infections (Cellulitis, erysipelas, epiglottitis, osteomyelitis, scarlet fever and meningitis) • Pitted scars
  42. CONGENITAL DEFECTS IN BABIES • Damage to brain: encephalitis, microcephaly, hydrocephaly, aplasia of brain • Damage to the eye: microphthalmia, cataracts, chorioretinitis, optic atrophy • Other neurological disorder: damage to cervical and lumbosacral spinal cord, motor/sensory deficits, absent deep tendon reflexes, anisocoria/Horner's syndrome • Damage to body: hypoplasia of upper/lower extremities, anal and bladder sphincter dysfunction • Skin disorders: (cicatricial) skin lesions, hypo pigmentation
  43. LABORATORY DIAGNOSIS • Most rapid and sensitive  Examination of vesicle fluid under electron microscope.  Round particles which may be used for cultivation.  Scrapings of floor of vesicles show multinucleated giant cells coloured by Giemsa Stain.  Serology for epidemiological surveys.
  44. CONTROL • No specific treatment for chickenpox  Notification.  Isolation of cases for about 6 days after onset of rash.  Disinfection of articles soiled by nose and throat discharges.  Antiviral drugs provide effective therapy for varicella (acyclovir, valaciclovir, famiciclovir and foscarnet)
  45. PREVENTION  Varicella zoster immunoglobulin (VZIG)  VZIG givenwithin 72 hours of exposure has been recommended for prevention  Dosage:1.25-5ml intramuscularly  Used for immunosuppressed contacts of acute cases or newborn contacts  Provide improvement in high risk children with varicella
  46. VACCINE  Monovalent vaccine  Oneor two dose schedule (0.5 mlsubcutaneous injection)  For children between 12-18months  Twodose schedule for persons aged>13years  Minimum interval between doses6weeks  Combination vaccines(MMRV) for children9 months to 12years  Duration of immunity probably 10years
  47. DIFFERENCE BETWEEN SMALL POX AND CHICKEN POX
  48. DIFFERENCE BETWEEN SMALL POX AND CHICKEN POX Small pox Chickenpox Incubation 12 days(7-17) 15 days(7-21) Prodromal Severe Mild Distribution ofrash Centrifugal Centripetal Palmsand soles involved Not involved Axilla free Axilla affected Extensor surfaces Flexor surfaces Characteristics of rash Deep seated Superficial Multilocular, umbilicated Unilocular, dew drop Onestageat atime Pleomorphic No inflammation around the vesicles Inflammation seen
  49. DIFFERENCE BETWEEN SMALL POX AND CHICKEN POX Small pox Chickenpox Evolution of rash Slowand majestic, passing through definite stagesof macule, papule, vesicle and pustule Very rapid Scabs10-14days Scabsin 4-7days Fever Subsideswith appearance of rash, may rise again at the pustular stage Feverappears with eachfresh crop of rash
Publicité